Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suqin He

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Molecular Cancer Therapeutics|January 9, 2014
Overcoming acquired BRAF inhibitor resistance in melanoma via targeted inhibition of Hsp90 with ganetespibJaime Acquaviva, Donald L Smith, John-Paul Jimenez, et al.
Journal of Integrative Plant Biology|August 13, 2025
Dynamic 3D chromatin organization and epigenetic regulation of gene expression in peanut nodulesLixiang Wang, Chunhai Mai, Suqin He, et al.
BMC Genomics|February 11, 2025
Transcriptome and WGCNA reveals the potential genetic basis of photoperiod-sensitive male sterility in soybeanYuhua Yang, Suqin He, Lihong Xu, et al.
International Journal of Oncology|November 16, 2012
Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expressionSuqin He, Chaohua Zhang, Ayesha A Shafi, et al.
Plos One|January 19, 2012
Mitochondrial electron transport is the cellular target of the oncology drug elesclomolRonald K Blackman, Kahlin Cheung-Ong, Marinella Gebbia, et al.
Investigational New Drugs|January 10, 2012
Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer modelsDavid A Proia, Jim Sang, Suqin He, et al.
International Journal of Nanomedicine|March 14, 2022
Dual pH-Responsive and Tumor-Targeted Nanoparticle-Mediated Anti-Angiogenesis siRNA Delivery for Tumor TreatmentXiangyang Zhang, Bin Qin, Min Wang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|December 9, 2025
Topotactic Phase Transition in Epitaxial La<sub>0.7</sub>Sr<sub>0.3</sub>MnO<sub>3-δ</sub> Films Induced by Oxygen Getter Assisted Thermal AnnealingChenyang Yin, Lei Cao, Xue Bai, et al.
Molecular Cancer Research : MCR|May 3, 2014
FGFR3 translocations in bladder cancer: differential sensitivity to HSP90 inhibition based on drug metabolismJaime Acquaviva, Suqin He, Chaohua Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2013
Preclinical activity profile and therapeutic efficacy of the HSP90 inhibitor ganetespib in triple-negative breast cancerDavid A Proia, Chaohua Zhang, Manuel Sequeira, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|January 9, 2014
Overcoming acquired BRAF inhibitor resistance in melanoma via targeted inhibition of Hsp90 with ganetespibJaime Acquaviva, Donald L Smith, John-Paul Jimenez, et al.
Journal of Integrative Plant Biology|August 13, 2025
Dynamic 3D chromatin organization and epigenetic regulation of gene expression in peanut nodulesLixiang Wang, Chunhai Mai, Suqin He, et al.
BMC Genomics|February 11, 2025
Transcriptome and WGCNA reveals the potential genetic basis of photoperiod-sensitive male sterility in soybeanYuhua Yang, Suqin He, Lihong Xu, et al.
International Journal of Oncology|November 16, 2012
Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expressionSuqin He, Chaohua Zhang, Ayesha A Shafi, et al.
Plos One|January 19, 2012
Mitochondrial electron transport is the cellular target of the oncology drug elesclomolRonald K Blackman, Kahlin Cheung-Ong, Marinella Gebbia, et al.
Investigational New Drugs|January 10, 2012
Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer modelsDavid A Proia, Jim Sang, Suqin He, et al.
International Journal of Nanomedicine|March 14, 2022
Dual pH-Responsive and Tumor-Targeted Nanoparticle-Mediated Anti-Angiogenesis siRNA Delivery for Tumor TreatmentXiangyang Zhang, Bin Qin, Min Wang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|December 9, 2025
Topotactic Phase Transition in Epitaxial La<sub>0.7</sub>Sr<sub>0.3</sub>MnO<sub>3-δ</sub> Films Induced by Oxygen Getter Assisted Thermal AnnealingChenyang Yin, Lei Cao, Xue Bai, et al.
Molecular Cancer Research : MCR|May 3, 2014
FGFR3 translocations in bladder cancer: differential sensitivity to HSP90 inhibition based on drug metabolismJaime Acquaviva, Suqin He, Chaohua Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2013
Preclinical activity profile and therapeutic efficacy of the HSP90 inhibitor ganetespib in triple-negative breast cancerDavid A Proia, Chaohua Zhang, Manuel Sequeira, et al.
Pageof 5